82 FR 42363 - Notice Pursuant to the National Cooperative Research and Production Act of 1993-The National Institute for Innovation in Manufacturing Biopharmaceuticals

DEPARTMENT OF JUSTICE
Antitrust Division

Federal Register Volume 82, Issue 172 (September 7, 2017)

Page Range		42363-42363
FR Document		2017-18992

Federal Register, Volume 82 Issue 172 (Thursday, September 7, 2017)

[Federal Register Volume 82, Number 172 (Thursday, September 7, 2017)]
[Notices]
[Page 42363]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-18992]



[[Page 42363]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--The National Institute for Innovation in 
Manufacturing Biopharmaceuticals

    Notice is hereby given that, on July 18, 2017, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), the University of Delaware, doing 
business as The National Institute for Innovation in Manufacturing 
Biopharmaceuticals (``NIIMBL''), has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing (1) the identities of the parties to the venture 
and (2) the nature and objectives of the venture. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: University of Delaware, Newark, DE; Purdue 
University, West Lafayette, IN; North Carolina State University, 
Raleigh, NC; Rensselaer Polytechnic Institute, Troy, NY; Johns Hopkins 
University, Baltimore, MD; Regents of University of Minnesota, 
Minneapolis, MN; National Institute for Pharmaceutical Technology and 
Education, Inc., Minneapolis, MN; University of Massachusetts, Lowell, 
MA; Southwest Research Institute, San Antonio, TX; Tulane University, 
New Orleans, LA; UNCW Research Foundation, or its assignee University 
of North Carolina at Wilmington, Wilmington, NC; Carnegie Mellon 
University, Pittsburgh, PA; East Carolina University, Greenville, NC; 
University of Georgia Research Foundation, Athens, GA; Texas A&M 
University System, College Station, TX; Clemson University, Clemson, 
SC; The Pennsylvania State University, University Park, PA; Georgia 
Tech Research Corporation, Atlanta, GA; Massachusetts Institute of 
Technology, Cambridge, MA; University of Maryland College Park, College 
Park, MD; Worcester Polytechnic Institute, Worcester, MA; Genentech, 
San Francisco, CA; Stratophase LP, Romsey, UNITED KINGDOM; Chromatan 
Corporation, State College, PA; ILC Dover LP, Frederica, DE; Sudhin 
Biopharma Co., Superior, CO; Artemis Biosystems, Inc., Cambridge, MA; 
Commissioning Agents, Indianapolis, IN; Unum Therapeutics, Inc., 
Cambridge, MA; RoosterBio, Inc., Avondale, PA; University of Maryland 
Baltimore, Baltimore, MD; Forsyth Technical Community College, Winston-
Salem, NC; University of Pennsylvania, Philadelphia, PA; Celgene 
Corporation, Summit, NJ; North Carolina Central University, Durham, NC; 
Massachusetts Life Sciences Center, Waltham, MA; North Carolina 
Biotechnology Center, Research Triangle Park, NC; Akron Biotechnology, 
LLC, Boca Raton, FL; and Accugenomics, Inc., Wilmington, NC. The 
general area of NIIMBL's planned activity is to engage in collaborative 
activities with the goals of: (a) Accelerating biopharmaceutical 
manufacturing innovation, (b) supporting the development of standards 
that enable more efficient and rapid manufacturing capabilities, and 
(c) educating and training a world-leading biopharmaceutical 
manufacturing workforce. Additional information about NIIMBL can be 
obtained from Dr. Kelvin Lee, Institute Director, NIIMBL, 15 Innovation 
Way, Newark, DE 19711, [email protected] and (302) 831-3716.

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-18992 Filed 9-6-17; 8:45 am]
 BILLING CODE P

Federal Register / Vol. 82, No. 172 / Thursday, September 7, 2017 / Notices 42363

DEPARTMENT OF JUSTICE IN; Unum Therapeutics, Inc., project remains open, and Node.js
Cambridge, MA; RoosterBio, Inc., Foundation intends to file additional
Antitrust Division Avondale, PA; University of Maryland written notifications disclosing all
Baltimore, Baltimore, MD; Forsyth changes in membership.
Notice Pursuant to the National Technical Community College, On August 17, 2015, Node.js
Cooperative Research and Production Winston-Salem, NC; University of Foundation filed its original notification
Act of 1993—The National Institute for Pennsylvania, Philadelphia, PA; pursuant to Section 6(a) of the Act. The
Innovation in Manufacturing Celgene Corporation, Summit, NJ; North Department of Justice published a notice
Biopharmaceuticals Carolina Central University, Durham, in the Federal Register pursuant to
Notice is hereby given that, on July NC; Massachusetts Life Sciences Center, Section 6(b) of the Act on September 28,
18, 2017, pursuant to Section 6(a) of the Waltham, MA; North Carolina 2015 (80 FR 58297).
Biotechnology Center, Research Triangle The last notification was filed with
National Cooperative Research and
Park, NC; Akron Biotechnology, LLC, the Department on May 26, 2017. A
Production Act of 1993, 15 U.S.C. 4301
Boca Raton, FL; and Accugenomics, notice was published in the Federal
et seq. (‘‘the Act’’), the University of
Inc., Wilmington, NC. The general area Register pursuant to Section 6(b) of the
Delaware, doing business as The
of NIIMBL’s planned activity is to Act on June 20, 2017 (82 FR 28092).
National Institute for Innovation in
Manufacturing Biopharmaceuticals engage in collaborative activities with Patricia A. Brink,
(‘‘NIIMBL’’), has filed written the goals of: (a) Accelerating Director of Civil Enforcement, Antitrust
notifications simultaneously with the biopharmaceutical manufacturing Division.
Attorney General and the Federal Trade innovation, (b) supporting the [FR Doc. 2017–18991 Filed 9–6–17; 8:45 am]
Commission disclosing (1) the identities development of standards that enable
BILLING CODE P
of the parties to the venture and (2) the more efficient and rapid manufacturing
nature and objectives of the venture. capabilities, and (c) educating and
The notifications were filed for the training a world-leading
biopharmaceutical manufacturing DEPARTMENT OF LABOR
purpose of invoking the Act’s provisions
limiting the recovery of antitrust workforce. Additional information Employee Benefits Security
plaintiffs to actual damages under about NIIMBL can be obtained from Dr. Administration
specified circumstances. Kelvin Lee, Institute Director, NIIMBL,
Pursuant to Section 6(b) of the Act, 15 Innovation Way, Newark, DE 19711, 188th Meeting of the Advisory Council
the identities of the parties to the info@niimbl.org and (302) 831–3716. on Employee Welfare and Pension
venture are: University of Delaware, Patricia A. Brink, Benefit Plans; Notice of
Newark, DE; Purdue University, West Teleconference Meeting
Director of Civil Enforcement, Antitrust
Lafayette, IN; North Carolina State Division. Pursuant to the authority contained in
University, Raleigh, NC; Rensselaer [FR Doc. 2017–18992 Filed 9–6–17; 8:45 am] Section 512 of the Employee Retirement
Polytechnic Institute, Troy, NY; Johns BILLING CODE P Income Security Act of 1974 (ERISA), 29
Hopkins University, Baltimore, MD; U.S.C. 1142, the 188th open meeting of
Regents of University of Minnesota, the Advisory Council on Employee
Minneapolis, MN; National Institute for DEPARTMENT OF JUSTICE Welfare and Pension Benefit Plans (also
Pharmaceutical Technology and known as the ERISA Advisory Council)
Education, Inc., Minneapolis, MN; Antitrust Division will be held as a teleconference on
University of Massachusetts, Lowell, September 25, 2017.
MA; Southwest Research Institute, San Notice Pursuant to the National The meeting will take place in C5521
Antonio, TX; Tulane University, New Cooperative Research and Production Room 4, U.S. Department of Labor, 200
Orleans, LA; UNCW Research Act of 1993—Node.js Foundation Constitution Avenue NW., Washington,
Foundation, or its assignee University of Notice is hereby given that, on August DC 20210. Public access is available
North Carolina at Wilmington, 14, 2017, pursuant to Section 6(a) of the only in this room (i.e. not by telephone).
Wilmington, NC; Carnegie Mellon National Cooperative Research and The meeting will run from 10:00 a.m. to
University, Pittsburgh, PA; East Carolina Production Act of 1993, 15 U.S.C. 4301 approximately 3:00 p.m. The purpose of
University, Greenville, NC; University et seq. (‘‘the Act’’), Node.js Foundation the open meeting is to discuss reports/
of Georgia Research Foundation, (‘‘Node.js Foundation’’) has filed written recommendations for the Secretary of
Athens, GA; Texas A&M University notifications simultaneously with the Labor on the issues of (1) Reducing the
System, College Station, TX; Clemson Attorney General and the Federal Trade Burden and Increasing the Effectiveness
University, Clemson, SC; The Commission disclosing changes in its of Mandated Disclosures with respect to
Pennsylvania State University, membership. The notifications were Employment-Based Health Benefit Plans
University Park, PA; Georgia Tech filed for the purpose of extending the in the Private Sector, and (2) Mandated
Research Corporation, Atlanta, GA; Act’s provisions limiting the recovery of Disclosure for Retirement Plans—
Massachusetts Institute of Technology, antitrust plaintiffs to actual damages Enhancing Effectiveness for Participants
Cambridge, MA; University of Maryland under specified circumstances. and Sponsors. Descriptions of these
College Park, College Park, MD; Specifically, BitRock, Inc. d/b/a topics are available on the Advisory
Worcester Polytechnic Institute, Bitnami, San Francisco, CA, has been Council page of the EBSA Web site at
Worcester, MA; Genentech, San added as a party to this venture. http://www.dol.gov/ebsa/aboutebsa/
mstockstill on DSK30JT082PROD with NOTICES

Francisco, CA; Stratophase LP, Romsey, Also, Sphinx Co. Ltd., Hanoi, erisa_advisory_council.html.
UNITED KINGDOM; Chromatan VIETNAM, has withdrawn as a party to Organizations or members of the
Corporation, State College, PA; ILC this venture. public wishing to submit a written
Dover LP, Frederica, DE; Sudhin No other changes have been made in statement may do so by submitting 30
Biopharma Co., Superior, CO; Artemis either the membership or planned copies on or before September 18, 2017
Biosystems, Inc., Cambridge, MA; activity of the group research project. to Larry Good, Executive Secretary,
Commissioning Agents, Indianapolis, Membership in this group research ERISA Advisory Council, U.S.

VerDate Sep<11>2014 17:42 Sep 06, 2017 Jkt 241001 PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 E:\FR\FM\07SEN1.SGM 07SEN1

Document Created: 2017-09-07 02:01:58
Document Modified: 2017-09-07 02:01:58

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		82 FR 42363

82 FR 42363 - Notice Pursuant to the National Cooperative Research and Production Act of 1993-The National Institute for Innovation in Manufacturing Biopharmaceuticals

DEPARTMENT OF JUSTICEAntitrust Division

Federal Register Volume 82, Issue 172 (September 7, 2017)

DEPARTMENT OF JUSTICE
Antitrust Division